Journal of
AIDS and HIV Research

  • Abbreviation: J. AIDS HIV Res.
  • Language: English
  • ISSN: 2141-2359
  • DOI: 10.5897/JAHR
  • Start Year: 2009
  • Published Articles: 283

Full Length Research Paper

Human immunodeficiency virus and hepatitis B virus (HIV/HBV) co-infection in people living with HIV/AIDs identified in Yaoundé Central Hospital, Cameroon: Seroprevalence and impact on the disease progression

Djuidje Ngounoue Marceline
  • Djuidje Ngounoue Marceline
  • Department of Biochemistry, Faculty of Science, University of Yaoundé I, Cameroon.
  • Google Scholar
Ambassa Axel Cyriaque
  • Ambassa Axel Cyriaque
  • Department of Biochemistry, Faculty of Science, University of Yaoundé I, Cameroon.
  • Google Scholar
Guiateu Tamo Ida Marlene
  • Guiateu Tamo Ida Marlene
  • Department of Biochemistry, Faculty of Science, University of Yaoundé I, Cameroon.
  • Google Scholar
Moundipa Fewou Paul
  • Moundipa Fewou Paul
  • Department of Biochemistry, Faculty of Science, University of Yaoundé I, Cameroon.
  • Google Scholar


  •  Received: 08 March 2017
  •  Accepted: 10 April 2017
  •  Published: 30 June 2017

References

Dieterich DT (2007).Special considerations and treatment of patients with HBV-HIV coinfection. Antivir. Ther. 12:H43-H51.

 

Faul F, Erdfelder E, Buchner A, Lang AG (2009). Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav. Res. Methods 41:1149-1160.
Crossref

 
 

Faul F, Erdfelder E, Lang, AG, Buchner A (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39:175-191.
Crossref

 
 

Gita R, Brodie D (2013).Women and HIV in Sub-Saharan Africa. AIDS Res. Ther. 10:30.
Crossref

 
 

Jobarteh M, Marine M, Ingrid P, Adam J, Ramu SN, Abraham A, Kevin P, Matt C, Andrew A, Sarah R-J, Hilton W, Richard T, Assan J, Maïmouna M (2010). Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. Virol J. 7:230.
Crossref

 
 

Laurent C, Bourgeois A, Mpoudi-N E, Kouanfack C, Ciaffi L, Nkoue N (2010). High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy. British HIV Ass. HIV Med. 11:85-89.
Crossref

 
 

Mabala R (2006). From HIV prevention to protection: addressing the vulnerability of girls and young women in urban areas. Environ. Urban 18 (2):407-432.
Crossref

 
 

Nagu TJ, Bakari M, Matee M (2008). Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 8:416.
Crossref

 
 

National Institute of Statistics (2011). Cameroon Demographic and Health Survey and Multiple Indicators Cluster Survey DHS-MICS. HIV prevalence and associated factors. pp. 265-285.

 
 

Noah ND, Njouom R, Bonny A, Pirsou P, Meli J, Biwole Sida M (2011). HBs antigen prevalence in blood donors and the risk of transfusion of hepatitis B at the Central hospital of Yaoundé, Cameroun. Open J. Gastroenterol. 1(02):23.
Crossref

 
 

Nyirenda M, Beadsworth M, Stephany P, Hart C, Hart I, Munthali C (2008). Prevalence of infection with hepatitis B and C virus and co-infection with HIV in medical inpatients in Malawi. J. Infect. Dis. 57:72-77.

 
 

Obi SO, Baba HA, Baba MM, Amilo GI, Bukar A (2012). The Effect of Co-infection of HIV and Hepatotropic Viruses on Selected Biochemical and Haematological Markers of Patients in Northeastern Nigeria. Int. J. Trop. Dis. Health 4:568-581.
Crossref

 
 

Ochola E, Ocama P, Orach CG (2013). High burden of hepatitis B infection in Northen Uganda: Results of a population-based survey. BMC Public Health 13(1):727.
Crossref

 
 

Odenyo H, Schoub B, Ally R, Kairu S, Segal I (2000). Hepatitis B and C virus infections and liver function in AIDS patients at Chrishanibaragwanath hospital Johannesburg. East Afr. Med. 77(1):13-15.

 
 

Olufemi A, Emmanuel A, Zaccheus A, Ibrahim W, Funmilayo E, Patience A (2009). Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J. Infect. Dev. Ctries. 3(5):369-375.

 
 

Pratt DS, Kaplan MM (2000). Evaluation of abnormal liver enzyme results in asymptomatic patients. New England J. Med. 342:1266-711.
Crossref

 
 

The Joint United Nations Programme on HIV and AIDS (UNAIDS) (2016). Global AIDS Update 2016.

 
 

The Joint United Nations Programme on HIV and AIDS (UNAIDS) (2016). Fact Sheet 2016.

 
 

WHO (World Health Organization) (2013). Global policy report on the prevention and control of viral hepatitis in WHO Member States 2013: ISBN 978 92 4 156463 2.

 
 

WHO (World Health Organization) (2016). HIV and hepatitis coinfections: Available at: 

View

 
 

Yohannes Z, Wondemagegn M, Mulat Yimer, Bayeh A (2014). Seroprevalenceand risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Nortwest Ethiopia: a cross sectional study. BMC Infect. Dis. 14:118.
Crossref

 
 

Zhou J, Dore GJ, Zhang F, Lim PL, Chen YM (2007). TREAT Asia HIV Observational Database. Hepatitis B and C virus co-infection in The TREAT Asia HIV Observational Database. J. Gastroenterol Hepatol. 22:1510-1518.
Crossref

 
 

Zoufaly A, Onyoh EF, Tih PM, Awasom CN, Feldt T (2012). High prevalence of hepatitis B and syphilis co-infections among HIV patients initiating antiretroviral therapy in the north-west region of Cameroon. Int. J. STD AIDS. 23:435-438.
Crossref